Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Double blind randomized phase IV clinical trial to evaluate the efficacy of fluvastatin on inflammatory markers in the haemodynamic progression of degenerative aortic stenosis. The AORTICA 1 study.

Trial Profile

Double blind randomized phase IV clinical trial to evaluate the efficacy of fluvastatin on inflammatory markers in the haemodynamic progression of degenerative aortic stenosis. The AORTICA 1 study.

Suspended
Phase of Trial: Phase IV

Latest Information Update: 19 Jan 2018

At a glance

  • Drugs Fluvastatin (Primary)
  • Indications Aortic valve stenosis
  • Focus Biomarker; Therapeutic Use
  • Acronyms AORTICA-1
  • Most Recent Events

    • 11 Jan 2018 Planned End Date changed from 1 Nov 2014 to 1 Jan 2018.
    • 03 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top